购物车
- 全部删除
- 您的购物车当前为空
SOR-C13 TFA,一种羧基末端截短肽,是一种高亲和力的 TRPV6拮抗剂,IC50值为 14 nM。TRPV6 是一种非电压门控钙通道,与乳腺癌的恶性肿瘤和预后不良有关。SOR-C13 TFA 具有抗癌活性。
SOR-C13 TFA,一种羧基末端截短肽,是一种高亲和力的 TRPV6拮抗剂,IC50值为 14 nM。TRPV6 是一种非电压门控钙通道,与乳腺癌的恶性肿瘤和预后不良有关。SOR-C13 TFA 具有抗癌活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | SOR-C13 TFA, a truncated carboxy-terminal peptide, serves as a potent TRPV6 antagonist, demonstrating high affinity with an IC 50 value of 14 nM. TRPV6, a non-voltage-gated calcium channel linked to malignancy and poor prognosis in breast cancer, is effectively targeted by SOR-C13 TFA, indicating its anticancer activity [1]. |
分子量 | 1679.84 |
分子式 | C74H117F3N20O21 |
存储 | keep away from moisture | Shipping with blue ice. |
评论内容